Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-genfit-ipsens-liver-disease-drug-2024-06-10/
https://www.globenewswire.com/news-release/2024/06/04/2893223/23024/en/Intercept-Presents-New-Sub-Analyses-of-Phase-3-POISE-Data-Showcasing-the-Effect-of-OCA-on-Key-Liver-Biomarkers-in-Patients-with-PBC-at-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/29/2889815/23024/en/Intercept-Announces-New-Data-to-be-Presented-at-the-European-Association-for-the-Study-of-the-Liver-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/20/2884808/23024/en/Intercept-Presents-New-Sub-Analyses-of-Phase-3-POISE-Data-Showcasing-the-Effect-of-OCA-on-Key-Liver-Biomarkers-and-Fibrosis-in-Patients-with-PBC-at-Digestive-Disease-Week-2024.html
https://www.globenewswire.com/news-release/2024/05/18/2884546/23024/en/Intercept-Presents-New-Data-Demonstrating-the-Impact-of-OCA-Bezafibrate-Combination-Therapy-on-ALP-and-Metabolic-Outcomes-After-Six-Months-of-Treatment-at-Digestive-Disease-Week-20.html
https://www.globenewswire.com/news-release/2024/05/09/2878727/23024/en/Intercept-Announces-New-PBC-Data-Analyses-to-be-Presented-at-Digestive-Disease-Week-2024-Conference.html
https://www.globenewswire.com//news-release/2024/02/29/2837979/23024/en/Intercept-Announces-FDA-Acceptance-of-Supplemental-New-Drug-Application-for-Ocaliva-obeticholic-acid-for-the-Treatment-of-PBC.html
https://www.globenewswire.com//news-release/2023/11/13/2779021/23024/en/Intercept-Announces-New-Phase-2-Data-Showing-Significant-Impact-of-OCA-Bezafibrate-Combination-on-Normalization-of-Multiple-Key-Biomarkers-of-PBC-Induced-Liver-Damage-at-AASLD-The-.html
https://www.globenewswire.com//news-release/2023/11/10/2778265/23024/en/Intercept-Announces-New-Findings-from-Long-term-Extension-of-Landmark-POISE-Trial-in-PBC-Showing-Importance-of-Biomarkers-Beyond-ALP-at-AASLD-The-Liver-Meeting-2023.html
https://www.globenewswire.com//news-release/2023/11/08/2776377/23024/en/Alfasigma-completes-acquisition-of-Intercept-Pharmaceuticals-Inc.html